Member Info for Timster

Great interview I think it does sound it could apply to ava6k.

"But let me give you an example. First, I would say this is not the right place for first in human studies, early drug development, early biomarker development. But let's say you had approved drugs that are being tested for a new application and you really don't need a re-abrogation of the safety data. These are drugs that you have a vast amount of experience with in other diseases, and you already have some preliminary data that you have efficacy in the question that you're trying to answer.
In that circumstance, you could create a really streamlined clinical trial in which you really focus on the question at hand, and you could forsake or forego a lot of the data that's collected in any study and that frequently in any study is really barely used."

They were on "BBC look north" once

https://avacta.com/avacta-featured-on-bbc-look-north/

Be sure to bring this up Tuesday morning.

Should get us down to my target 20p placing price.

Back to 40p on vaccine news :(

No bank holidays in the states or in hospitals for the unfortunate patients who have STS.

Dr Tap will have a full book by Tuesday, wouldn't want to be out....

Watch out agentb, breaking cover, they are onto you. Check the windows and doors, bolt the bunker hatch ...

STOP SHOUTING

Cwafee machines fired up....

Thanks Rorkes, makes sense.

After all this time they can't be far off knowing what the dose will be to be fair.

It is entertaining, death spiral still in play.

There's one fella so panicked he seems to be struggling to put a coherent sentence together.

Can't wait till the internet is on over there at 2.30

Oh yeah I know 1b is nailed on and it's within these next 3 cohorts from what Al said.

Just read some class twitter posts, it's all a ramp by Al, we are still in a death spiral.

"Already know have a dose for P1b"

What makes you think that?

Guessing that will be on the 17th. Should be interesting as big Al said he will also cover some of the AVA6000 science day detail in layman terms.
And 3996 sounds like it could do a very good job of taking a very large share of the market.

You'd think so yeah, big Al still alluded to his half year target in his interview yesterday.

You're logged on with the wrong account Derek, we were talking about truant.

Interesting in this rns they say the US sites are recruiting for STS, are they only recruiting STS for phase 1a too?

Active enrolment has now begun for soft tissue sarcoma patients to the phase 1 clinical trial.

So cohorts 5,6 and 7 may start to see efficacy in the states.

Only if truant comes too.

Yeeehaaaaa

Great news, never been wrong to date....